Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma (NCT02673333)

🧪 Interventions in This Study

• Pembrolizumab (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• University of Michigan (Data or Specimen Analysis Only) — Ann Arbor, Michigan
• Memorial Sloan Kettering Cancer Center — New York, New York

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Adrenocortical Carcinoma

• Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC) — Bethesda, Maryland
• Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma — New York, New York
• Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma — Basking Ridge, New Jersey

Explore by condition: All Adrenocortical Carcinoma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.